Free Newsletter
Obama says FDA due for 'complete review'
He may have been prompted by peanut butter, but President Obama's promise of a "complete review" at the FDA is sure to range beyond food safety. In the wake of the big salmonella outbreak traced to Peanut Corp. of America, Obama says the agency hasn't been on the ball. "[T]he FDA has not been able to catch some of these things as quickly as I expect them to," the president said.
Meanwhile, the president is just days away from appointing a permanent chief to head up the embattled agency. Just how many days? Press Secretary Robert Gibbs didn't say.
As you know, a host of critics have been calling for an overhaul of the FDA. Everyone from congressional committees to the agency's own science board to the Government Accountability Office have weighed in, saying that the FDA is underfunded, understaffed and underperforming. The agency has netted some additional money and staff, but experts say it's still not enough to put it on the right track.
- read the story in USA Today
- get more from the Washington Post
Related Articles:
GAO calls FDA a 'high-risk' problem
Nissen, Juma have plan for Obama
Acting FDA chief promises science, not politics
FDA scientists plea for agency reform
Sweep the FDA clean, Stupak says
Kindler: Take politics out of the FDA
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: